Imexpharm’s sustainability efforts recognized at CSA 2025
Imexpharm earns CSA 2025 recognition for advancing sustainable pharma practices through ESG, innovation, and community-focused initiatives.
Topic: Top 50 Corporate Sustainability Awards
Imexpharm recognized at Top 50 Corporate Sustainability Awards
The Imexpharm Pharmaceutical Joint Stock Company has been listed in the Top 50 Corporate Sustainability Awards 2023 held by the Nhip Cau Dau Tu - The BusinessReview magazine.